Abstract: Artemisinin from the plant Artemisia annua is the most potent pharmaceutical for the treatment of malaria. In the plant, the sesquiterpene cyclase amorphadiene synthase,acytochrome-dependent CYP450, and an aldehyde reductase convert farnesyl diphosphate (FDP) into dihydroartemisinic aldehyde (DHAAl), whichi sakey intermediate in the biosynthesis of artemisinin and as emisynthetic precursor for its chemical synthesis.H ere,w er eport ac hemoenzymatic process that is able to deliver DHAAl using only the sesquiterpene synthase from acarefully designed hydroxylated FDP derivative.This process,whichreverses the natural order of cyclization of FDP and oxidation of the sesquiterpene hydrocarbon, provides as ignificant improvement in the synthesis of DHAAl and demonstrates the potential of substrate engineering in the terpene synthase mediated synthesis of highvalue natural products.
The sesquiterpenoid endoperoxide artemisinin (1)i sw idely used as af irst-line treatment for malaria in combination therapy. [1] Although elegant organic syntheses of artemisinin have been published, [2] thew orldwide supply of 1 predominantly relies on extraction from the plant Artemisia annua. [3] Thed emand for artemisinin is mainly from the developing world, which requires the drug to be produced at low cost. Currently the most efficient way to synthesize artemisinin is to combine biosynthesis with chemical steps.C entral to the biosynthesis of 1 (Scheme 1) is the class Is esquiterpene cyclase amorphadiene synthase (ADS), which catalyzes the conversion of (E,E)-farnesyl diphosphate (FDP, 2)i nto amorpha -4,11-diene (3) . In this complex reaction cascade, two 6-membered rings,f our stereocentres,a nd two double bonds are formed with exquisite regio-and stereochemical control in one step. [4] Dihydroartemisinic aldehyde (DHAAl, 4)c an be made from amorpha -4,11-diene (3) e ither through at hree-step chemical synthesis or by combining ab iooxidation with two chemical steps. [5] Compound 4 can then be converted into 1 chemically or enzymatically in four wellestablished steps. [2a, 6] It is noteworthy that an elegant semisynthetic pathway has been developed that uses ADS and five other enzymes in yeast to produce artemisinic acid (5) , which is then converted into dihydroartemisinic acid (6)b yt ransition metal-catalyzed hydrogenation. Thep harmaceutical company Sanofi scaled up this process in 2014 but the manufacture was discontinued owing to strong market forces, [7] thus highlighting the need for ecologically friendly, low-cost alternatives for the production of artemisinin.
Herein, we report an ovel chemoenzymatic process that exploits the substrate promiscuity of ADS to convert the hydroxylated FDP analogue 7 into the synthetic intermediate DHAAl (4) . In contrast to existing procedures,t his process, which reverses the natural order of cyclization of FDP and oxidation of the sesquiterpene hydrocarbon, significantly shortens the synthesis of dihydroartemisinic aldehyde (4) , in that it uses only one enzyme and requires as ingle oxidation step that occurs prior to the ADS-catalyzed cyclization to 4. Thep rocess avoids several redox steps after the cyclization since it bypasses the formation of the intermediate amorphadiene (3)a ltogether (Scheme 1).
Amorphadiene synthase (ADS) catalyzes the Mg
2+
-dependent conversion of its natural substrate FDP (2;s ee Figure S13 in the Supporting Information) along ac omplex reaction path that involves isomerization of the 2,3-double bond from the E to the Z configuration and 1,6-cyclization to generate abisabolyl cation (8) , followed by a1,3-hydride shift from C1 to C7 and 1,10-cyclization to the amorphyl cation (9) . Finally,deprotonation at C12 or C13 generates amorpha-4,11-diene (3;Scheme 2and Figures S4, S22, S23). [8] Scheme 1. Top: Current routes to artemisinin. Bottom:One-step ADScatalyzed synthesis of dihydroartemisinic aldehyde (DHAAl, 4)f rom 12-hydroxyfarnesyl diphosphate (7).
Many sesquiterpene synthases display some degree of substrate promiscuity,and are able to convert methylated and fluorinated farnesyl diphosphate analogues into modified terpenoids. [9] [10] [11] In this work, we investigated for the first time the potential of asesquiterpene synthase to accept ahydroxylated FDP analogue as as ubstrate.I np articular, we asked whether ADS [11b] could convert 12-hydroxyfarnesyl diphosphate (7; [12] Scheme 1) into dihydroartemisinic aldehyde (4) via a1 2-hydroxyamorphyl cation (OH-9;S cheme 3). It is known that a-hydroxylated carbocations such as OH-9 can isomerize under acidic conditions to aldehydes.
[13] The electrophilic nature of terpene synthase chemistry combined with the inherent reactivity of a-hydroxylated carbocations such as OH-9 should therefore lead to aldehyde 4.
Diphosphate 7 was synthesized in two steps from commercially available (E,E)-farnesyl chloride (10;S cheme 4). Thes hort synthesis involved low-temperature acid-catalyzed selenium dioxide oxidation of 10 [14] and diphosphorylation of the resulting chloride 11 [15] (Tables S1, S2 and Figures S13-S16 [17a] Thes tructure of the major aldehyde was deduced to be the (11S)-4 epimer based on its diagnostic 1 H-NMR signals at d H 5.27 (s,H 2), 1.64 (s,3 -Me), 1.07 (d, J = 6.8 Hz, 11-Me), and 0.87 ppm (d, J = 6.5 Hz, 7-Me), which are complementary to those of (11R)-4 at d H 5.13 (s,H2), 1.64 (s, 3-Me), 1.06 (d, J = 6.9 Hz, 11-Me), and 0.87 ppm (d, J = 6.5 Hz, 7-Me;F igure 1). In addition, the epimeric nature of (11R)-4 and (11S)-4 is further supported by the epimerization of the corresponding esters that is described later in Scheme 6. Analysis of the NMR sample by GC-MS showed a7 :2 mixture of (11S)-4 and (11R)-4,i na ddition to approximately 10 %o faminor product (Figure 2 ) that we tentatively propose to be the enol form (12)o fa ldehyde 4 Scheme 2. Synthesis of amorphadiene (3)from FDP (2)i nthe plant A. annua.
Scheme 3. The ADS-catalyzed synthesis of 4 from 12-hydroxyfarnesyl diphosphate (7)a nd 12-acetoxyfarnesyl diphosphate( 13)via carbocations OH-9 and 15,r espectively. 1 HNMR (500 MHz, CDCl 3 )o fthe pentane-extractable products generated by ADS-catalyzed turnover of 7 after silica-gel purification, with inserts showing the diagnostic peaks assigned to H12, H2, 11-CH 3 ,and 7-CH 3 .
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Communications 4348 www.angewandte.org based on its identical MS spectrum ( Figure S3 ) with that of (11S)-4.T he MS spectra as well as the GC elution times of (11R)-4 (faster) and (11S)-4 are consistent with those reported previously. [17] Ther eaction mechanism for the conversion of FDP to amorphadiene (Scheme 2) suggests that enol 12 may initially be formed from carbocation OH-9 through deprotonation of either H a or H b (path a-b in Scheme 3) before 12 equilibrates to the observed mixture of epimers of 4 outside the active site of ADS.H owever incubations of diphosphate 7 with ADS in D 2 Ol ed to the exclusive production of deuterated (11S)-4 ( Figure S10) ;n o deuterated (11R)-4 was detected by GC-MS.T his observation indicates that only (11S)-4 can be formed via enol 12.
To further investigate the capability of ADS to act on unnatural substrates,1 2-acetoxyfarnesyl diphosphate (13) was prepared in three steps (32 %o verall yield) from known 1-O-THP-protected 12-hydroxyfarnesol [14] (Figures S17, S18) and incubated with ADS.G C-MS analysis revealed that the same three products were obtained as from incubations with diphosphate 7 (Figure 2and Figure S9 ). Theobservation that no vinyl acetate 14 is produced from 13 (Scheme 3) suggests that the enol 12 is not aproduct of ADS catalysis but is formed exclusively from (11S)-4 after its release from the active site.Control experiments excluded the presence of ester hydrolase activity in our enzyme preparations (see the Supporting Information). Remarkably,t he incubation of 13-acetoxyfarnesyl diphosphate (16,F igure S19) with ADS (Scheme 5) yielded (11S)-4 (93 %) and enol 12 (7 %; Figure 2a nd Figures S5, S6 ). Thea bsence of significant amounts of the (11R)-epimer of 4 implies that enol 12 does not revert to (11R)-4 under the reaction conditions (pH % 7.5;Scheme 3). These results strongly suggest that only one pathway operates to yield the observed epimeric mixture of aldehydes 4.Hence the formation of 4 from 7 (and 13)most likely proceeds through an oxygen-assisted non-stereospecific intramolecular [1, 2] -hydride shift from carbocation OH-9 (or 15 for 13;p aths aa nd bi nS cheme 3). Since the stable vinyl acetate 14 is not formed from 13-acetoxyfarnesyl diphosphate (16) , deprotonation of 17 via enol 12 to (11S)-4 appears unlikely.Hence astereospecific [1, 2] -hydride shift of H a from carbocation 17 most likely accounts for the exclusive formation of (11S)-4 (path ainScheme 5) from diphosphate 16.
To further advance this novel chemoenzymatic approach towards the production of artemisinin, the 2:3m ixture of (11R)a nd (11S)-4 was oxidized to the corresponding dihydroartemisinic acids (6)i n9 3% yield (Scheme 6), [2b] and subsequently converted into the corresponding dihydroartemisinic methyl esters (18)i n9 4% yield ( Figure S11 ). [18] Tr eatment of the esters with LDAu nder kinetic control resulted in a1 :1 mixture of (11R)-and (11S)-methyl esters ( Figure S28 ). (11R)-dihydroartemisinic methyl ester is the desired intermediate for the synthesis of artemisinin. [19] In conclusion, we have developed an efficient chemoenzymatic route to dihydroartemisinic aldehyde (4), am ajor intermediate in the production of artemisinin (1), the most important drug for the treatment of malaria. We have for the first time shown that hydroxylated FDP analogues can be accepted as substrates by sesquiterpene synthases.Hence our work offers anovel "reversed biosynthetic" approach for the synthesis of functionally diversified hydroxylated terpenoids. Thec hemical synthesis of such products is often difficult owing to the need to make several small rings with high stereo-and regiocontrol. Ther elatively high substrate promiscuity and the templating effect of the active site allow terpene synthases to chaperone unnatural substrates along well-defined reaction paths to specific products with high fidelity.T his design offers ap romising approach for the production of high-value terpenoids and terpene alkaloids [11a] Figure 2. GC chromatogram(TIC) of the pentane-extractable products from an incubation of diphosphate 7 (blue), 13 (red), and 16 (green) with ADS. GC peaks were assigned as putative enol 12 (21.24 min), and aldehydes (11R)-4 (22.29 min), and (11S)-4 (22.48 min).
Scheme 5. ADS-catalyzed production of (11S)-4 from 13-acetoxyfarnesyl diphosphate( 16)via carbocation 17.
Scheme 6. Synthesis of dihydroartemisinic acid methyl ester (18) .
that is complementary to conventional synthetic and biosynthetic procedures.
